Company Overview
| Company Name | Medical Knowledge Management Co., Ltd. |
| Established | August 8, 2024 |
| Representative | Kozo Nishimori, President |
| Capital | 9 million JPY |
| Address | KDDI Annex Building 1F, No.27 2-3-3 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan |
| Phone | 050-7110-5980 |
| Invoice No. | T4011201025723 |
| Business Activities | 1) Strategic Partnerships in Pharmaceuticals Supporting pharmaceutical companies through collaboration and knowledge-sharing to drive innovation and create value. 2) Training & Capability Building Designing and delivering customized training and educational programs to empower teams and enhance organizational performance. |
| Company Name | Medical Knowledge Management Co., Ltd. |
| Established | August 8, 2024 |
| Representative | Kozo Nishimori, President |
| Capital | 9 million JPY |
| Address | KDDI Annex Building 1F, No.27 2-3-3 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan |
| Phone | 050-7110-5980 |
| Invoice No. | T4011201025723 |
| Business Activities | 1) Strategic Partnerships in Pharmaceuticals Supporting pharmaceutical companies through collaboration and knowledge-sharing to drive innovation and create value. 2) Training & Capability Building Designing and delivering customized training and educational programs to empower teams and enhance organizational performance. |
Leadership Profile
President
Kozo Nishimori
【Professional Background】
Kozo Nishimori has nearly 30 years of frontline experience in pharmaceutical marketing, gained through diverse roles at global pharmaceutical companies.
His career spans product marketing, new product planning, mature brand management, and market research, including experience at the U.S. headquarters. As Marketing Director, he led numerous brand strategies across different stages of the product lifecycle.
In 2024, he founded Medical Knowledge Management Co., Ltd., with a mission to create new value for both companies and society by promoting the effective use of medical and marketing knowledge. Drawing on his extensive experience, he aspires to serve as a “knowledge bridge” that connects healthcare and society, driving innovation and value creation every day.
He also serves as a Visiting Professor at iU (Professional University of Information and Management for Innovation) and is the author of “Practical Pharmaceutical Marketing” (Medical Review Co., Ltd.).
Message
Medical knowledge and information should be shared more broadly—and more accurately—with society.
With this conviction, I founded Medical Knowledge Management Co., Ltd.
The valuable expertise and know-how held by pharmaceutical companies have the potential to make a profound contribution to the health and well-being of society. Yet, from my long experience in pharmaceutical marketing, I have felt a strong sense of challenge: that this value is not always reaching society in the way it should.
Our mission is “Opening up healthcare to society through creativity and innovation.”
Together with pharmaceutical and healthcare-related companies, we strive to deliver medical and health-related knowledge to society in more useful and impactful ways. By unlocking and sharing this value, we can enrich people’s lives, raise health literacy, and contribute to building a healthier and happier society.
As a “knowledge bridge” connecting healthcare and society, I truly look forward to new encounters and collaborations with all of you.
Kozo Nishimori
President
Medical Knowledge Management Co., Ltd.
Executive Counsel
Akihisa Harada, M.D., Ph.D.
Representative Director of the Board, Chief Executive Officer, Mitsubishi Tanabe Pharma Corporation
External Committee Member, Kanazawa University Management Council
Dr. Harada graduated from Kanazawa University Faculty of Medicine, holding both an M.D. and Ph.D. in medicine.
After conducting basic research in immunology at university, he joined Pfizer, where he was responsible for drug development and later became Head of R&D. He subsequently transitioned to the business division, ultimately serving as President & Representative Director of Pfizer Japan.
With a distinguished career spanning both pharmaceutical R&D and business management at a global company, Dr. Harada brings extensive expertise across the entire pharmaceutical value chain.
Since September 2025, he has served as Representative Director of the Board, Chief Executive Officer of Mitsubishi Tanabe Pharma Corporation.
Executive Medical Advisor
Yoko Fujimoto, M.D., Ph.D., MBA
Current Positions
Managing Director and Chief Medical Officer (CMO), Rohto Pharmaceutical Co., Ltd.
Scientific Advisor, Life Science Company, AGC Inc.
Program Officer (PO) and Evaluation Committee Member, AMED (Japan Agency for Medical Research and Development) – AIMGAIN (Alliance program for Innovative Medical/healthcare research by Government-Academia-Industry Collaboration)
External Committee Member, Institute of Science Tokyo
Previous Roles
Former Business Unit Head, Member of the Board, and Corporate Officer, Pfizer Japan Inc.
M.D. and Ph.D. in Medicine, Tokyo Medical and Dental University (now Institute of Science Tokyo, Faculty of Medicine)
MBA, Graduate School of Management, Nagoya University of Commerce & Business
Dr. Fujimoto possesses extensive knowledge and experience across the entire pharmaceutical value chain, from basic drug discovery research, clinical development, manufacturing and supply chain management, and marketing, to clinical practice as a prescribing physician.
Opening up healthcare to society through creativity and innovation.
Opening up healthcare to society through creativity and innovation.